Cargando…

The changing epidemiology worldwide of Mycobacterium ulcerans

Mycobacterium ulcerans is recognised as the third most common mycobacterial infection worldwide. It causes necrotising infections of skin and soft tissue and is classified as a neglected tropical disease by the World Health Organization (WHO). However, despite extensive research, the environmental r...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Brien, D. P., Jeanne, I., Blasdell, K., Avumegah, M., Athan, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518549/ https://www.ncbi.nlm.nih.gov/pubmed/30293536 http://dx.doi.org/10.1017/S0950268818002662

Ejemplares similares

Cell-mediated and serology-based tests for Mycobacterium ulcerans disease: A systematic review and meta-analysis
por: Avumegah, Michael S., et al.
Publicado: (2020)

Spontaneous healing of Mycobacterium ulcerans disease in Australian patients
por: O’Brien, Daniel P., et al.
Publicado: (2019)

Increased Severity and Spread of Mycobacterium ulcerans, Southeastern Australia
por: Tai, Alex Y.C., et al.
Publicado: (2018)

Environmental risk factors associated with the presence of Mycobacterium ulcerans in Victoria, Australia
por: Blasdell, Kim R., et al.
Publicado: (2022)

Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes
por: O’Brien, Daniel P., et al.
Publicado: (2015)

Mycobacterium ulcerans culture results according to duration of prior antibiotic treatment: A cohort study
por: Tweedale, Brodie, et al.
Publicado: (2023)

Successful treatment of Mycobacterium ulcerans osteomyelitis with minor surgical debridement and prolonged rifampicin and ciprofloxacin therapy: a case report
por: O'Brien, Daniel P, et al.
Publicado: (2008)

Mycobacterium Ulcerans Treatment – Can Antibiotic Duration Be Reduced in Selected Patients?
por: Cowan, Raquel, et al.
Publicado: (2015)

Mycobacterium ulcerans Disease: Experience with Primary Oral Medical Therapy in an Australian Cohort
por: Friedman, N. Deborah, et al.
Publicado: (2013)

Exposure Risk for Infection and Lack of Human-to-Human Transmission of Mycobacterium ulcerans Disease, Australia
por: O’Brien, Daniel P., et al.
Publicado: (2017)

Clinical Features and Risk Factors of Oedematous Mycobacterium ulcerans Lesions in an Australian Population: Beware Cellulitis in an Endemic Area
por: O'Brien, Daniel P., et al.
Publicado: (2014)

Successful Outcomes with Oral Fluoroquinolones Combined with Rifampicin in the Treatment of Mycobacterium ulcerans: An Observational Cohort Study
por: O'Brien, Daniel P., et al.
Publicado: (2012)

Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease
por: O’Brien, Daniel P., et al.
Publicado: (2018)

Risk Factors for Mycobacterium ulcerans Infection, Southeastern Australia
por: Quek, Tricia Y.J., et al.
Publicado: (2007)

Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections
por: O’Brien, Daniel P, et al.
Publicado: (2013)

Corticosteroid Use for Paradoxical Reactions during Antibiotic Treatment for Mycobacterium ulcerans
por: Friedman, N. Deborah, et al.
Publicado: (2012)

A Major Role for Mammals in the Ecology of Mycobacterium ulcerans
por: Fyfe, Janet A. M., et al.
Publicado: (2010)

A Sero-epidemiological Approach to Explore Transmission of Mycobacterium ulcerans
por: Ampah, Kobina Assan, et al.
Publicado: (2016)

Molecular and epidemiological characterization of recurrent Mycobacterium ulcerans infections in Benin
por: Gnimavo, Ronald, et al.
Publicado: (2021)

Mycobacterium ulcerans Disease, Peru
por: Guerra, Humberto, et al.
Publicado: (2008)

Update on Medicinal Plants with Potency on Mycobacterium ulcerans
por: Tsouh Fokou, Patrick Valere, et al.
Publicado: (2015)

Sero-Epidemiology as a Tool to Screen Populations for Exposure to Mycobacterium ulcerans
por: Yeboah-Manu, Dorothy, et al.
Publicado: (2012)

A human model of Buruli ulcer: The case for controlled human infection and considerations for selecting a Mycobacterium ulcerans challenge strain
por: Muhi, Stephen, et al.
Publicado: (2023)

Clinical, Microbiological and Pathological Findings of Mycobacterium ulcerans Infection in Three Australian Possum Species
por: O'Brien, Carolyn R., et al.
Publicado: (2014)

Ongoing Genome Reduction in Mycobacterium ulcerans
por: Rondini, Simona, et al.
Publicado: (2007)

Mycobacterium ulcerans Treatment Costs, Australia
por: Drummond, Christina, et al.
Publicado: (2004)

Profiling Mycobacterium ulcerans with hsp65
por: Leão, Sylvia Cardoso, et al.
Publicado: (2005)

Histopathologic Features of Mycobacterium ulcerans Infection
por: Guarner, Jeannette, et al.
Publicado: (2003)

Mycobacterium ulcerans mycolactones-fungi crosstalking
por: Hammoudi, Nassim, et al.
Publicado: (2019)

Translocating Mycobacterium ulcerans: An experimental model
por: Hammoudi, Nassim, et al.
Publicado: (2020)

In-vitro Activity of Avermectins against Mycobacterium ulcerans
por: Omansen, Till F., et al.
Publicado: (2015)

Potential Animal Reservoir of Mycobacterium ulcerans: A Systematic Review
por: Singh, Avishek, et al.
Publicado: (2018)

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012)

Mycobacterium ulcerans Disease with Unusual Sites Not to Be Ignored
por: Abdoulaye, Sangaré, et al.
Publicado: (2014)

The Incubation Period of Buruli Ulcer (Mycobacterium ulcerans Infection)
por: Trubiano, Jason A., et al.
Publicado: (2013)

Profiling Mycobacterium ulcerans: sporulation, survival strategy and response to environmental factors
por: Ayerakwa, Eunice Ampadubea, et al.
Publicado: (2023)

Understanding the transmission of Mycobacterium ulcerans: A step towards controlling Buruli ulcer
por: Muleta, Anthony J., et al.
Publicado: (2021)

In Vitro Susceptibility of Mycobacterium ulcerans Isolates to Selected Antimicrobials
por: Owusu, Enid, et al.
Publicado: (2017)

Tropical Plant Extracts Modulating the Growth of Mycobacterium ulcerans
por: Mougin, Benjamin, et al.
Publicado: (2015)

In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaera
por: Pidot, Sacha J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vt42daubh30mavrmut67kkfbkk